Expediting Drug Development of Novel Therapeutics: Regulatory and Commercialization Implications of Digital Twin Technology in Clinical Trials

Jan. 24, 2024—By Colleen Carroll Clinical trials are a major bottleneck for new drug development.[1] No drug will make it to market without first meeting rigorous safety and efficacy standards. This requires extensive testing across multiple phases of clinical trials, which take, on average, ten and a half years.[2] But advances in AI may transform clinical trials...

Read more